Redwood Investment Management LLC purchased a new stake in Fortrea Holdings Inc. (NASDAQ:FTRE – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 92,033 shares of the company’s stock, valued at approximately $3,212,000. Redwood Investment Management LLC owned approximately 0.10% of Fortrea […]
Fortrea (NASDAQ:FTRE – Get Free Report) and Laboratory Co. of America (NYSE:LH – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Insider & Institutional Ownership 95.9% of Laboratory […]
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Fortrea to related companies based on the strength of its dividends, profitability, analyst recommendations, risk, earnings, institutional ownership and valuation. Analyst Recommendations This is a […]
TD Cowen assumed coverage on shares of Fortrea (NASDAQ:FTRE – Free Report) in a research note published on Wednesday, MarketBeat reports. The firm issued a hold rating and a $27.00 price target on the stock. Several other research firms have also issued reports on FTRE. Deutsche Bank Aktiengesellschaft cut their price target on Fortrea from […]
Mizuho started coverage on shares of Fortrea (NASDAQ:FTRE – Free Report) in a report issued on Tuesday morning, Marketbeat.com reports. The brokerage issued a neutral rating and a $27.00 price target on the stock. A number of other equities analysts have also issued reports on the stock. Robert W. Baird raised shares of Fortrea from […]